• Publications
  • Influence
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.
OBJECTIVE The Systemic Lupus International Collaborating Clinics (SLICC) group revised and validated the American College of Rheumatology (ACR) systemic lupus erythematosus (SLE) classificationExpand
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
The MISEV2018 guidelines include tables and outlines of suggested protocols and steps to follow to document specific EV-associated functional activities, and a checklist is provided with summaries of key points. Expand
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.
An association with SLE, the patient's sex, and the patient’s age at disease onset can modify the disease expression and define specific subsets of APS. Expand
Interobserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis.
High interobserver agreement rates for the identification of synovitis and bone erosions are achieved using an introduced semiquantitative scoring system for ultrasonography of finger and toe joints in RA. Expand
Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction
Selective COX-2 inhibitors in all dosages and nonselective NSAIDs in high dosages increase mortality in patients with previous MI and should therefore be used with particular caution in these patients. Expand
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients
Patients with APS still develop significant morbidity and mortality despite current treatment, and it is imperative to increase the efforts in determining optimal prognostic markers and therapeutic measures to prevent these complications. Expand
Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides
Age at menarche was the only examined factor that was significantly associated with both serologic subtypes of RA, and major differences in risk factor profiles suggest distinct etiologies for anti-CCP-positive and anti- CCP-negative RA. Expand
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
Treating-to-target-in-SLE (T2T/SLE) recommendations were developed by a large task force of multispecialty experts and a patient representative and it is anticipated that ‘treating- to-target’ can and will be applicable to the care of patients with SLE. Expand
Cancer risk in systemic lupus: an updated international multi-centre cohort study.
There is clearly an increased risk of NHL, and cancers of the vulva, lung, thyroid, and possibly liver in SLE relative to the general population, and it remains unclear to what extent the association with NHL is mediated by innate versus exogenous factors. Expand
Diagnostic classification of non-specific low back pain. A new system integrating patho-anatomic and clinical categories
Identifying relevant subgroups of nonspecific low back pain patients may improve research efficiency and clinical outcomes. This article presents available data supporting the rationale behind a newExpand